Article |
By Nikolay Krumov and Jonas Mueller,Lonza
Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges?
Need to find out how to calibrate your size exclusion chromatography (SEC) column? Or how different additives affect your results? Read these useful insights.
Cost efficiencies and expertise again go hand in hand, with companies often outsourcing or partnering primarily to gain access to manufacturing know-how.
Learn how having the right predictive sciences capabilities integrated into R&D workflows delivers a scientific decision support environment that reduces time and expense, improves quality, enhances collaboration, and accelerates innovation in bringing new drugs to market.
The successful transition from initial synthesis of an API to a kilogram-scale route requires expert analysis and design and a balance of economic, regulatory, and time constraints.
Dr. Claudia Müller answers attendee questions from a webinar about the complex path to a successful product launch, which requires a holistic development strategy driven by a well-defined target product profile.
November 15, 2022 | 11:00 a.m. EST
New molecular formats and other recombinant proteins present facility- and product-specific development requirements that often render platform approaches inappropriate. Accordingly, addressing the most pressing challenges in process and analytical development associated with novel molecular biologic formats requires a keen understanding of the applicable tools and strategies.
